… While endoscopic submucosal dissection (ESD) is recognized as a minimally invasive …
This multicenter, single-arm, confirmatory trial was conducted to evaluate the efficacy and …

… There are few reports on the technical difficulty of gastric endoscopic submucosal
dissection … non-randomized confirmatory trial of expanded indication criteria of ESD (JCOG0607). …

… Absolute and expanded indications for endoscopic submucosal dissection in early gastric
cancer … A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal …

… In total, 554 patients are expected to be included in the trial. After providing written informed
consent, patients will undergo a D2 gastrectomy in a non-randomized, prospective study. …

… A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal
dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (…

… Endoscopic submucosal dissection (ESD) remains an investigational issue for early gastric
cancer (EGC) with expanded indications … -randomised single-arm confirmatory trials, not both-…

… expanded criteria for curative resection. The risk of bias was assessed with the Cochrane
tool for non-randomized studies. The risk ratio (RR) was estimated using a fixed-effect model. …

… gastric cancers that meet an expanded indication of ER, a prospective … confirmatory trial
for patients with ESD for undifferentiated-type EGCs that meet the expanded indication of ER …

… A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal
dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (…

… ESD for superficial SCC, with absolute indication for lesions with m1–m2 involvement, and
expanded indication for m3 or superficial submucosal (< 200 µm invasion depth) involvement …